John P Kirkpatrick
Overview
Explore the profile of John P Kirkpatrick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
3242
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Marasco M, Kirkpatrick J, Nanna V, Carlomagno T
Methods Mol Biol
. 2023 Sep;
2705:25-37.
PMID: 37668967
Nuclear magnetic resonance (NMR) spectroscopy is the method of choice for studying the dynamics of biological macromolecules in solution. By exploiting the intricate interplay between the effects of protein motion...
12.
Nanna V, Marasco M, Kirkpatrick J, Carlomagno T
Methods Mol Biol
. 2023 Sep;
2705:3-23.
PMID: 37668966
Nuclear magnetic resonance (NMR) spectroscopy is a powerful technique to solve the structure of biomolecular complexes at atomic resolution in solution. Small proteins such as Src-homology 2 (SH2) domains have...
13.
Vaios E, Winter S, Shih H, Dietrich J, Peters K, Floyd S, et al.
Cancers (Basel)
. 2023 May;
15(9).
PMID: 37173897
Radiation necrosis, also known as treatment-induced necrosis, has emerged as an important adverse effect following stereotactic radiotherapy (SRS) for brain metastases. The improved survival of patients with brain metastases and...
14.
Natesan D, Carpenter D, Giles W, Oyekunle T, Niedzwiecki D, Reitman Z, et al.
Adv Radiat Oncol
. 2023 May;
8(4):101211.
PMID: 37152484
Purpose: Existing brain metastasis prognostic models do not identify patients at risk of very poor survival after radiation therapy (RT). Identifying patient and disease risk factors for 30-day mortality (30-DM)...
15.
Carpenter D, Leng J, Arshad M, Giles W, Kirkpatrick J, Floyd S, et al.
JAMA Netw Open
. 2023 Apr;
6(4):e2310117.
PMID: 37099292
Importance: Clinical trials for metastatic malignant neoplasms are increasingly being extended to patients with brain metastases. Despite the preeminence of progression-free survival (PFS) as a primary oncologic end point, the...
16.
Carpenter D, Fairchild A, Adamson J, Fecci P, Sampson J, Herndon J, et al.
Adv Radiat Oncol
. 2023 Feb;
8(2):101166.
PMID: 36845614
Purpose: Hypofractionated stereotactic radiosurgery (HF-SRS) with or without surgical resection is potentially a preferred treatment for larger or symptomatic brain metastases (BMs). Herein, we report clinical outcomes and predictive factors...
17.
Carpenter D, Natarajan B, Arshad M, Natesan D, Schultz O, Moravan M, et al.
Cancers (Basel)
. 2022 Nov;
14(21).
PMID: 36358606
Stereotactic radiosurgery (SRS) is a standard of care for many patients with brain metastases. To optimize post-SRS surveillance, this study aimed to validate a previously published nomogram predicting post-SRS intracranial...
18.
A Deep Learning-Based Computer Aided Detection (CAD) System for Difficult-to-Detect Brain Metastases
Fairchild A, Salama J, Wiggins W, Ackerson B, Fecci P, Kirkpatrick J, et al.
Int J Radiat Oncol Biol Phys
. 2022 Oct;
115(3):779-793.
PMID: 36289038
Purpose: We sought to develop a computer-aided detection (CAD) system that optimally augments human performance, excelling especially at identifying small inconspicuous brain metastases (BMs), by training a convolutional neural network...
19.
Vaios E, Batich K, Buckley A, Dunn-Pirio A, Patel M, Kirkpatrick J, et al.
Oncotarget
. 2022 Oct;
13:1165.
PMID: 36289014
No abstract available.
20.
Halasz L, Attia A, Bradfield L, Brat D, Kirkpatrick J, Laack N, et al.
Pract Radiat Oncol
. 2022 Jul;
12(5):370-386.
PMID: 35902341
Purpose: This guideline provides evidence-based recommendations for adults with isocitrate dehydrogenase (IDH)-mutant grade 2 and grade 3 diffuse glioma, as classified in the 2021 World Health Organization (WHO) Classification of...